Buzzy and vibracool: fda-cleared pain relief technology for all ages
Buzzy and VibraCool offer FDA-cleared pain relief through patented neuromodulation and thermal therapies, effectively reducing pain from injections, surgeries, and chronic conditions. Suitable for both children and adults, these devices eliminate the need for opioids in many scenarios.
Overview
Buzzy and VibraCool are innovative pain relief devices designed to offer immediate comfort through a combination of neuromodulatory frequencies and thermal applications. Originally developed to alleviate needle-related pain, these devices now serve a broader range of uses, including arthritis, post-surgical pain, and chronic conditions. Buzzy effectively reduces needle pain, while VibraCool, a patented Class 1 wearable device, targets post-operative and rehabilitation pain using advanced ice pack technology. These devices have proven successful in over 100 peer-reviewed studies and are utilized globally, demonstrating their efficacy in reducing procedural pain.
Technical specifications
- Neuromodulation Technology: Utilizes a 200Hz frequency to block pain signals via purinergic signaling in the dorsal horn.
- Thermal Therapy: Features lightweight, thermally optimized ice packs that provide effective cooling without the risk of frostbite.
- Versatile Applications: Effective for needle pain, arthritis, surgical recovery, and more, adaptable for both pediatric and adult users.
- Proven Efficacy: Supported by extensive research, including randomized controlled trials and meta-analyses.
- Global Reach: Available in 28 countries with over 200 million uses.
Technology readiness level
These devices have achieved Technology Readiness Level 9, indicating they are fully operational and have been validated through successful deployment in real-world conditions. Future studies and potential acquisitions are ongoing, further expanding their application in telemedicine and sports medicine.
About Pain Care Labs a dba of MMJ Labs LLC
Pain Care Labs is a medical technology company that develops noninvasive, drug-free pain relief solutions using its proprietary M-Stim neuromodulation platform. Founded by pediatric emergency physician Dr. Amy Baxter, the company engineers wearable devices that combine thermal and mechanical vibration frequencies to inhibit pain pathways. Its flagship products include Buzzy, a device designed to block needle and procedural pain, and VibraCool, which provides vibrating cryotherapy for musculoskeletal pain, injuries, and sports recovery. The company's technology is supported by numerous independent peer-reviewed studies and FDA clearances, aiming to provide alternatives to pharmacological interventions such as opioids.
These products are utilized across hospitals, clinics, and home environments to improve patient comfort during medical procedures and support physical rehabilitation. By leveraging gate control theory, the technology offers a safe, reusable, and cost-effective method for managing acute and chronic pain. The organization, originally established as MMJ Labs LLC, has received significant research funding from the National Institutes of Health (NIH) and continues to innovate in the field of external neuromodulation to address widespread medical challenges, including needle phobia and opioid dependency.
delivered to your inbox.